Cargando…
Long-Term (1-Year) Safety and Efficacy of a Single 6-mL Injection of Hylan G-F 20 in Indian Patients with Symptomatic Knee Osteoarthritis
INTRODUCTION: The prevalence of symptomatic knee osteoarthritis (OA) among Asians ≥65 years is estimated to double by 2040. This study was designed to evaluate the safety and efficacy of a single, 6-mL intra-articular injection of hylan G-F 20 in Indian patients with knee OA at 26 weeks through to 5...
Autores principales: | Pal, Sarvajeet, Thuppal, Sreedhar, Reddy, K.J, Avasthi, Sachin, Aggarwal, Anish, Bansal, Himanshu, Mohanasundaram, Senthilnathan, Bailleul, Francois |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196249/ https://www.ncbi.nlm.nih.gov/pubmed/25328555 http://dx.doi.org/10.2174/1874312901408010054 |
Ejemplares similares
-
Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial
por: Chevalier, X, et al.
Publicado: (2009) -
Hylan GF-20 Viscosupplementation in the Treatment of Symptomatic Osteoarthritis of the Knee: Clinical Effect Survivorship at 5 Years
por: Boutefnouchet, Tarek, et al.
Publicado: (2017) -
Open-label Study of Initial and Repeat Treatment Cycles of Hylan G-F 20 in Patients with Symptomatic Knee Osteoarthritis
por: Heger, Robert, et al.
Publicado: (2016) -
Viscosupplementation for knee osteoarthritis: a focus on Hylan G-F 20
por: Webb, David, et al.
Publicado: (2018) -
IMPROVEMENTS IN HIP OSTEOARTHRITIS WITH LAVAGE, TRIAMCINOLONE AND HYLAN G-F20
por: REZENDE, MÁRCIA UCHÔA DE, et al.
Publicado: (2020)